Clinical trial
A Randomized, Multicenter, Open-label, Parallel, Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients Having Intermittent Claudication Among Chronic Artery Occlusive Disease
NCT06046196 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter, Open-label, Parallel, Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients Having Intermittent Claudication Among Chronic Artery Occlusive Disease
- Lead sponsor
- Yuhan Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 18, 2020
- Completion date
- March 9, 2023
- Enrollment
- 148 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.